AbbVie Full-Year Adjusted Diluted Earnings Per Share Guidance Range, Including Impact Of Q3 2023 Acquired IPR&D & Milestones Expense, Is $10.86-$11.06 Vs $11.07 Est
Portfolio Pulse from Benzinga Newsdesk
AbbVie has updated its full-year adjusted diluted earnings per share guidance range to $10.86-$11.06, including the impact of Q3 2023 acquired IPR&D and milestones expense. This is slightly below the estimated $11.07.
October 04, 2023 | 8:17 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
AbbVie's revised earnings guidance is slightly below the estimated $11.07, which may negatively impact investor sentiment.
AbbVie's revised earnings guidance is slightly below the estimated $11.07. This could lead to a negative sentiment among investors, potentially causing a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100